Pellegrini A, Pietrocola G
Microorganisms. 2024; 12(7).
PMID: 39065153
PMC: 11278874.
DOI: 10.3390/microorganisms12071385.
Lourenco A, Chuo S, Bohn M, Hann B, Khan S, Yevalekar N
MAbs. 2023; 15(1):2184197.
PMID: 36859773
PMC: 9988344.
DOI: 10.1080/19420862.2023.2184197.
Muller G, Muller T
Int J Mol Sci. 2022; 23(13).
PMID: 35806423
PMC: 9267055.
DOI: 10.3390/ijms23137418.
Stefanova V, Crowley V, Weckman A, Kain K
Front Immunol. 2022; 13:931321.
PMID: 35757694
PMC: 9226448.
DOI: 10.3389/fimmu.2022.931321.
Qin L, Wang L, Zhang J, Zhou H, Yang Z, Wang Y
Sci Adv. 2022; 8(21):eabn3774.
PMID: 35613265
PMC: 9132454.
DOI: 10.1126/sciadv.abn3774.
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
Zhai B, Tian H, Sun J, Zou J, Zhang X, Cheng J
J Transl Med. 2022; 20(1):135.
PMID: 35303878
PMC: 8932206.
DOI: 10.1186/s12967-022-03329-3.
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.
Kumar A, Buckley B, Ranson M
Biomolecules. 2022; 12(2).
PMID: 35204653
PMC: 8961517.
DOI: 10.3390/biom12020152.
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Masucci M, Minopoli M, Di Carluccio G, Motti M, Carriero M
Cancers (Basel). 2022; 14(3).
PMID: 35158766
PMC: 8833673.
DOI: 10.3390/cancers14030498.
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.
Metrangolo V, Ploug M, Engelholm L
Cancers (Basel). 2021; 13(21).
PMID: 34771541
PMC: 8582577.
DOI: 10.3390/cancers13215376.
uPAR: An Essential Factor for Tumor Development.
Lv T, Zhao Y, Jiang X, Yuan H, Wang H, Cui X
J Cancer. 2021; 12(23):7026-7040.
PMID: 34729105
PMC: 8558663.
DOI: 10.7150/jca.62281.
suPAR, a Circulating Kidney Disease Factor.
Wei C, Spear R, Hahm E, Reiser J
Front Med (Lausanne). 2021; 8:745838.
PMID: 34692736
PMC: 8526732.
DOI: 10.3389/fmed.2021.745838.
Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention.
Leth J, Ploug M
Front Cell Dev Biol. 2021; 9:732015.
PMID: 34490277
PMC: 8417595.
DOI: 10.3389/fcell.2021.732015.
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.
Gonias S
Am J Physiol Cell Physiol. 2021; 321(4):C721-C734.
PMID: 34406905
PMC: 8560384.
DOI: 10.1152/ajpcell.00269.2021.
The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A, Napolitano F, Montuori N, Ragno P
Int J Mol Sci. 2021; 22(8).
PMID: 33923400
PMC: 8073738.
DOI: 10.3390/ijms22084111.
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.
Bharadwaj A, Holloway R, Miller V, Waisman D
Cancers (Basel). 2021; 13(8).
PMID: 33921488
PMC: 8070608.
DOI: 10.3390/cancers13081838.
PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
Guo Q, Yaron J, Wallen 3rd J, Browder K, Boyd R, Olson T
Front Cardiovasc Med. 2021; 8:633212.
PMID: 33665212
PMC: 7921738.
DOI: 10.3389/fcvm.2021.633212.
The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis.
Napolitano F, Montuori N
J Clin Med. 2021; 10(3).
PMID: 33535668
PMC: 7867209.
DOI: 10.3390/jcm10030518.
Altered Protein Function Caused by AMD-associated Variant rs704 Links Vitronectin to Disease Pathology.
Biasella F, Plossl K, Karl C, Weber B, Friedrich U
Invest Ophthalmol Vis Sci. 2020; 61(14):2.
PMID: 33259607
PMC: 7718807.
DOI: 10.1167/iovs.61.14.2.
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.
Baart V, Houvast R, de Geus-Oei L, Quax P, Kuppen P, Vahrmeijer A
EJNMMI Res. 2020; 10(1):87.
PMID: 32725278
PMC: 7387399.
DOI: 10.1186/s13550-020-00673-7.
Characterization of an Extensive Interface on Vitronectin for Binding to Plasminogen Activator Inhibitor-1: Adoption of Structure in an Intrinsically Disordered Region.
Puster L, Stanley C, Uversky V, Curtis J, Krueger S, Chu Y
Biochemistry. 2019; 58(51):5117-5134.
PMID: 31793295
PMC: 7987228.
DOI: 10.1021/acs.biochem.9b00605.